ProMIS Neurosciences Reports Positive Top-Line Data from
Topline results demonstrated a favorable safety profile and tolerability across four ascending dose levels in healthy volunteers and showed dose ...
Read moreTopline results demonstrated a favorable safety profile and tolerability across four ascending dose levels in healthy volunteers and showed dose ...
Read moreNAARDEN, the Netherlands and MIAMI, July 26, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or ...
Read moreLOS ANGELES, July 23, 2024 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious ...
Read moreJuly 17, 2024 News Release Preliminary data suggests potential use beyond early AKI diagnosis for NGAL biomarker COPENHAGEN, Denmark and ...
Read more– 43% of Participants Showed Improvement on the UMSARS Activities of Daily Living Scale – – 29% of Participants had ...
Read moreMOUNTAIN VIEW, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- HeartFlow, a leader in non-invasive artificial intelligence (AI) heart care solutions, ...
Read moreProtective Effects of ANX007 on Visual Acuity and Vision Related Anatomical Measures in the Central Macula Will be Presented as ...
Read moreSOLANA BEACH, Calif., July 03, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling ...
Read moreMeta truly believes in innovation and creativity. It built technologies that revolutionized how people connect with each other or ...
Read moreWALTHAM, Mass., June 28, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.